Search results
Results From The WOW.Com Content Network
The Malay Dilemma. The Malay Dilemma ( Malay: Dilema Melayu) is a 1970 book by Malaysian politician and writer Mahathir Mohamad, who went on to be the country's longest serving Prime Minister . In it, Mahathir describes his interpretation of Malaysia's history in relation to its multi-ethnic society and racial tensions, and advocates for ...
MPH Group (M) Sdn Bhd. MPH Group Malaysia Sdn Bhd [2] is a Malaysian group of companies best known for its book retailing and online retailing services as well as being involved in the printing, publishing and distribution of books and library services in Malaysia and Singapore. Its bookstore chain, MPH Bookstores Sdn Bhd, headquartered in ...
Buku FIXI. Buku FIXI is a Malaysian independent publisher founded in 2011 by filmmaker Amir Muhammad. The company specializes not only in contemporary urban fiction - both in Malay and English - but also Malay translations of foreign titles, and graphic novels.
S. Southbound (publisher) Categories: Book publishing companies by country. Publishing companies of Malaysia.
www .malaysiarecords .com .my. The Malaysia Book of Records [1] (or MBR) is a Malaysian project to publish records set or broken by Malaysians. The project complements Prime Minister Mahathir Mohamad 's ' Malaysia Boleh! ' ( Malaysia Can! in English) campaign. [2] As with the Guinness World Records, there is an annually published book listing ...
Category: Books by publishing company of Malaysia. ... Matahari Books books (2 P) This page was last edited on 4 June 2020, at 16:04 (UTC). Text ...
lathouse.com.my. Dato' Mohammad Nor bin Mohammad Khalid ( Jawi: محمد نور بن محمد خالد; born 5 March 1951), more commonly known as Lat, is a Malaysian cartoonist. Winner of the Fukuoka Asian Culture Prize in 2002, Lat has published more than 20 volumes of cartoons since he was 13 years old. His works mostly illustrate Malaysia's ...
During Thursday night’s debate, President Joe Biden and former President Donald Trump spent a considerable amount of time trying to claim credit for lowering the high cost of insulin.